CLINICAL_TRIALS
trial_result
· 2015-11-20
Clinical Trial Update: Efficacy Confirmation Study of CDP870 in Early Rheumatoid Arthritis [Phase 3]
Summary
Phase 3 efficacy confirmation study of CDP870 in early rheumatoid arthritis has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2015-11-20